Cure Alzheimer's Fund

09/02/2026

Progress in Alzheimer’s research is giving us a clearer understanding of the disease and opening new possibilities for the future. Fueled by bold research, advances in diagnostics and treatment are changing how Alzheimer’s disease is detected and managed.

Explore the latest approaches to diagnosis and therapies available to patients and clinicians today: https://curealz.org/about-alzheimers/alzheimers-diagnostics-and-treatments/

08/31/2026

Every breakthrough in Alzheimer's research represents hope for millions of people living with the disease and the families who care for them. Now, your voice can help protect the scientific progress that makes these breakthroughs possible.

A proposed policy from the Office of Management and Budget (OMB) would change how federal research grants are awarded and managed, replacing scientific peer review with politically driven decision making and slowing breakthroughs in Alzheimer’s research.

Thanks to citizen advocacy from across the country, the Senate included a provision in the Continuing Resolution that would delay implementation of this rule until December 11th. However, the House must also act for the delay to become law. But a delay is not enough. Now is an important time to urge your elected officials to prevent the proposed rule from taking effect altogether and protect a research funding process guided by scientific expertise and rigorous evidence.

Learn more about the proposal, why it matters for Alzheimer's research, and how you can help: https://curealz.org/news-and-events/help-protect-independent-scientific-review-and-the-future-of-alzheimers-research/

Together, we can help protect the research that brings us closer to preventing, slowing, and one day ending Alzheimer's disease.

08/28/2026

August is National Make-A-Will Month, a reminder that planning for the future is one of the most meaningful ways to support the people and causes you care about.

After watching his father live with Alzheimer’s, longtime Cure Alzheimer’s Fund supporter Jerry Porzemsky chose to include CureAlz in his estate plans, creating a legacy that will help advance Alzheimer's research for years to come.

Read Jerry's story and learn how your legacy gift can help create a future free from Alzheimer's: https://curealz.org/news-and-events/create-a-legacy-that-supports-alzheimers-research/

08/21/2026

Congratulations to Cure Alzheimer’s Fund Research Leadership Group members Randall Bateman, M.D., and David Holtzman, M.D., co-founders of C2N Diagnostics, on the FDA clearance of the PrecivityAD2® blood test.

This important milestone is a powerful example of what can happen when we invest in moving bold scientific ideas from discovery to real-world impact, ultimately reaching the patients who need them.

CureAlz has long supported Drs. Bateman and Holtzman’s pioneering research into Alzheimer’s disease biology and biomarkers, including work that helped lay the scientific groundwork for advances in blood-based testing. We’re proud to see this foundational science continue to translate into meaningful progress for patients.

08/20/2026

Join us in welcoming Stephanie Wasco to the CureAlz team!

Stephanie Wasco has been appointed as Cure Alzheimer’s Fund’s new Executive Vice President of Marketing and Communications, and she brings with her deep experience in building brands across the life sciences, biomedical research, and nonprofit sectors. Stephanie will lead CureAlz’s marketing and communications strategy, advancing the shared mission of CureAlz while strengthening engagement with our donor community and the public. We are thrilled to have her on board.

Welcome, Stephanie!

Learn More: https://curealz.org/news-and-events/cure-alzheimers-fund-appoints-new-executive-vice-president-of-marketing-and-communications/

08/14/2026

Big impact often starts with small steps. Inspired by her family’s experience with Alzheimer’s disease, Alexa Burton has spent the past decade turning her love of running into a mission — raising tens of thousands of dollars to help accelerate Alzheimer’s research. Her story is a powerful reminder that you’re never too young to make a difference. Whether it’s a fun run, lemonade stand, bake sale, or community event, every effort helps move us closer to a future without Alzheimer’s disease.

Ready to turn your passion into purpose? Learn more about Alexa’s story and how you can get involved: https://curealz.org/news-and-events/small-steps-make-a-big-impact-the-power-of-youth-fundraising/

08/11/2026

Sleep is essential for brain health—but could it also play a role in preventing or slowing Alzheimer's disease?

Join CureAlz leadership and members of the Sleep & Circadian Rhythms Consortium as they discuss emerging research exploring how sleep and circadian disruption affects brain aging, inflammation, and Alzheimer’s pathology — and how improving sleep and circadian rhythms may offer new therapeutic opportunities.

Register today to join us live: https://curealz.org/news-and-events/webinar-sleep-circadian-rhythms-alzheimers-disease/

We hope to see you there! If you can’t attend the live session, register anyhow to receive a link to the recording after the webinar.

08/07/2026

Cure Alzheimer's Fund is proud to be an official charity partner of the 2026 Cambridge Half Marathon & 5K on October 31 and November 1 in Cambridge, Massachusetts! By joining Team CureAlz, you’ll help accelerate research focused on preventing, slowing, and reversing Alzheimer's disease.

Every step can help accelerate Alzheimer’s disease research.

Register today and secure your spot: https://runsignup.com/Race/74589/Charity/35225

07/31/2026

What if inflammation is a common thread connecting the diseases of aging, including Alzheimer's?

A compelling new New York Times Magazine article on chronic inflammation explains how immune activity throughout the body can influence brain health, among many other factors.

We're proud to see two members of Cure Alzheimer's Fund’s Research Leadership Group featured in the article. Dr. Jonathan Kipnis and Dr. Beth Stevens share their invaluable expertise which continues to reshape our understanding of Alzheimer's, from the brain's connection to the immune system to the role of microglia in maintaining, and potentially disrupting, neural networks.

We're always proud to support bold research that is revealing how the immune system may hold important clues for preventing, detecting, and treating Alzheimer's disease.

Read more: https://www.nytimes.com/interactive/2026/07/29/magazine/inflammation-chronic-immune-system-health.html

The discovery that chronic inflammation is a cause of myriad illnesses could be this century's biggest medical breakthrough.

07/28/2026

Join us in welcoming Katie Price to the CureAlz team as Senior Philanthropic Advisor! Katie has held leadership roles across philanthropy, higher education, and the arts, and brings a personal commitment to the fight against Alzheimer’s inspired by her grandfather. We're thrilled to have her join us!